. Au-total, 9%) ont bénéficié d'une injection de fondaparinux lors de la phase aigue du SCA non ST+, 29 patients (16%) en préhospitalier et 16 patients, pp.45-69

E. Batard, D. Trewick, and G. Lp, Le syndrome coronarien aigu sans sus-d??calage du segment ST aux urgences, R??animation, vol.13, issue.8, pp.13-507
DOI : 10.1016/S1624-0693(04)00152-5

V. Bargoin, SCA sans élévation de ST: les nouvelles recommandations européennes prennent en compte la sécurité. theheart.org, International Editions> Édition française> Sections> Actualités, 2007.

J. Goldstein, P. Wiel, E. Assez, and N. , Le syndrome coronarien aigu dans le cadre de l'urgence préhospitalière, Les Essemiels, vol.515, issue.26, 2005.

M. Ezzati, S. Hoorn, and A. Rodgers, Estimates of global and regional potentil health gains from reducing muliple major risk factors, The Lancet, vol.362, issue.9380, pp.271-80, 2003.
DOI : 10.1016/S0140-6736(03)13968-2

K. Fox, S. Goodman, and W. Klein, Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE), European Heart Journal, vol.23, issue.15, p.23, 2002.
DOI : 10.1053/euhj.2001.3081

H. Tunstall-pedoe, K. Kuulasmaa, and M. Mahonen, Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations, The Lancet, vol.353, issue.9164, pp.1547-57, 1999.
DOI : 10.1016/S0140-6736(99)04021-0

M. Montaye, P. Ducimetière, and J. Ruidavets, Le gradient Nord-Sud de la morbidité et de la mortalité coronaires en France: données récentes des registres français des cardiopathies ischémiques, BEH, vol.8, issue.9, pp.62-66, 1997.

A. Wagner, M. Montaye, and A. Bingham, Baisse globale de la mortalité mais pas de l'incidence de la maladie coronaire en France de, BEH, vol.8, issue.9, pp.65-71, 1997.

J. Ruidavcts, B. Haas, and M. Montaye, Létalité de l'infarctus du myocarde des patients hospitalisés et son évolution dans les trois registres français des cardiopathies ischémiques, pp.67-75, 2006.

I. Amouyel and P. , Maladies coronaires: existe-t-il encore une place pour le «French Paradox)}?, Rev Prat, vol.13, pp.1883-1890, 1999.

D. Arveiler, A. Wagner, and P. Ducimetière, Trends in coronary heart disease in France during the second half of the 1990s. Eur J Ca l'dia vase Prev Re, pp.209-224, 12005.

I. Amouyel and P. , Epidémiologie des syndromes coronaires aigus en France Société Française de Cardiologie. loi Bargoin V. GRACE montre que l'amélioration de la prise en charge des SCA a réduit la mortalité et l'insuffisance cardiaque. theheart.org, International Editions> Édition française> Sections> Actualités, 2007.

C. Granger and R. Goldberg, Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events, Archives of Internal Medicine, vol.163, issue.19, pp.2345-53, 2003.
DOI : 10.1001/archinte.163.19.2345

K. Fox, P. Steg, and K. Eagle, Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006, JAMA, vol.297, issue.17, pp.1892-900, 1999.
DOI : 10.1001/jama.297.17.1892

E. Pcterson, B. Shah, and L. Parsons, Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial 1nfarction l'rom, Alli Hearl J, vol.156, pp.1045-55, 1990.

E. Braunwald, E. Anlman, J. Beasley, and . Acc, ACC/AHA 2002 guideline update for the management of patients with unstable angina and non???ST-segment elevation myocardial infarction???summary article, Journal of the American College of Cardiology, vol.40, issue.7, pp.1366-74, 2002.
DOI : 10.1016/S0735-1097(02)02336-7

W. Rogers, P. Frederick, and E. Stoehr, Trends in presenting characteristics and hospital mortality among patient with ST-elevation and non ST-elevation myocardial infarction in the National Registry of Myocardial 1nfarction l'rom, Alli Hearl J, vol.156, pp.1026-1060, 1990.

S. Yusuf, F. Zhao, and S. Mehta, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Ellgi J Med, vol.345, pp.494-502, 2001.

C. Cannon, W. Weintraub, and L. Demopoulos, Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban, New England Journal of Medicine, vol.344, issue.25, pp.1879-87, 2001.
DOI : 10.1056/NEJM200106213442501

L. Mandelzweig, A. Battler, and V. Boyko, The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin, Ellr Hearl J, vol.27, pp.2285-93, 2004.

D. Hasdai, S. Behar, and L. Wallentin, A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS), European Heart Journal, vol.23, issue.15, pp.1190-201, 2002.
DOI : 10.1053/euhj.2002.3193

M. Bertrand, M. Simoons, and K. Fox, Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, European Heart Journal, vol.23, issue.23, pp.1809-1849, 2002.
DOI : 10.1053/euhj.2002.3385

. Cambou-lp and N. Danehin, Les registres: intérêts et limites. Société Française de Cardiologie CareNologie et /11aladies vasculaires, 2007.

. Bassand-lp, C. Hamm, and D. Ardissino, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology: reply, European Heart Journal, vol.29, issue.2, pp.1598-660, 2007.
DOI : 10.1093/eurheartj/ehm499

D. Karila-cohen and G. Steg, Infarctus du myocarde, pp.2-0210, 1998.

W. Kahle, H. Leonhardt, and P. W. Anatomie, Tome 2 viscères, 2" éd. Flammarion Médecine-Sciences, 1990.

P. Zipes, P. Libby, and R. Ronow, Brall/lll'ald's Heart Disease, 1987.

P. Oirai, Athérome: anatomie pathologique, physiopathologie, épidémiologie et facteurs de risque, prévention

H. Stary, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosc1erosis, Circulation, vol.895, pp.2462-78, 1994.

Z. Galis, G. Sukhova, and M. Lark, Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques., Journal of Clinical Investigation, vol.94, issue.6, pp.2493-503, 1994.
DOI : 10.1172/JCI117619

P. Moreno, E. Falk, and I. Palacios, Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture, Circulation, vol.90, issue.2, pp.775-783, 1994.
DOI : 10.1161/01.CIR.90.2.775

A. Cohen, Cardiologie et pathologie vasculaire, 1997.

/. Cardia, Presses Universitaires, pp.491-99, 1999.

. Quilici-1 and R. Gallo, Physiopathologie des syndromes coronariens aigus, AnJl Cardial Angéiol, vol.48, pp.9-10, 1999.

L. Capron, ÉvoluLion des théories sur l'athérosclérose. Rel, Prat, vol.46, pp.533-540, 1996.

H. Bauters and C. , Plaque d'athérome: aspects anatomopathologiques. Encyclopédie pratique du COEllr Maladie athéromatelfse, 2004.

A. L. -13-care, angioplastie facilitée par l'administration préhospitalière d'abciximab dans la prise en charge de l'infarctus du myocarde au SAMU 54 Th: Médecine: Université Henri Poincaré -1-1 Dinh-Xuan AT, pp.35-42, 2004.

P. Ganz, O. Hess, and M. Buechi, Rôle de la dysfonction endothéliale dans les maladies coronariennes et conséquences thérapeutiques. 46 e session scientifique annuelle de l'American College ofCardiology. Anaheim, Californie; 16-20 mars 1997 Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries, Circulation, vol.88, pp.2139-2187, 1993.

G. Mancini, G. Henry, and C. Macaya, Angiotensin-converting enzyme inhibition with quinapril improvcs endothelial vasoillotor dysfunction in patienLs with coronary artery disease. The Trial on Reversing Endothelial Dysfunction (TREND) Study, Circa/otilla, vol.94, pp.258-65, 1996.

A. Tl, I. Meredith, and A. Yeung, The effect of cholesterol-Iowering and antioxidant therapy on endothelium-dcpendent eoronary vasomotion, N Ellg J Med, vol.332, pp.488-93, 1995.

. Collet-lp and G. Montalescot, Rupture de plaque ct thrombose. Encyclopédie pratique dit COEur -Maladie athérofllateltse, pp.43-51, 2004.

. Bristol-myers and . Squibb, Pla vix: monographie scientifique, 1999.

L. Drouet, Thrombose et ses cibles thérapeutiques, Rev Prat, vol.49, pp.1617-1640, 1999.

M. Kroll, Platelets and shear stress, Blood, vol.88, pp.1525-1566, 1996.

R. Jcnnings, C. Steenbergen, . Jr, and K. Reimcr, Myocardial ischcmia and reperfusion, Monogr Pathol, vol.37, pp.47-80, 1995.

K. Reimer and R. Jcnnings, The "wavefront phenomenon" of myocardial ischemic cell death. TransI11ural progression of Ilccrosis within the frumework of ischemic bed size (myocardium at risk) and collateral flow. Lab II1I'est, pp.633-677, 1979.

J. Myers, M. Stirling, and M. Choy, Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography, Circulation, vol.74, issue.1, pp.164-172, 1986.
DOI : 10.1161/01.CIR.74.1.164

G. Heyndrickx, R. Millard, and R. Mcritchie, Regional myocardial functional and electrophysiologkal alterations after brief coronary artery occlusion in cansciaus dags, J Clin Im'est, vol.56, pp.978-85, 1975.

E. Braunwald and R. Kloner, The stunned myocardium: prolonged, postischemic ventricular dysfunction, Circulation, vol.66, issue.6, pp.1146-1155, 1982.
DOI : 10.1161/01.CIR.66.6.1146

G. Heusch and R. Schulz, Characterization of hibernating and stunned myocardium, European Heart Journal, vol.18, issue.suppl D, pp.102-112, 1997.
DOI : 10.1093/eurheartj/18.suppl_D.102

V. Piriau, . Lehot-11, and J. Obadia, Stunned and hibernating myocardium: an update for the anaesthetists, Canadian Journal of Anaesthesia, vol.255, issue.10, pp.997-1010, 1998.
DOI : 10.1161/01.CIR.96.9.2920

S. Rahimtoola, The hibernating myocardium, American Heart Journal, vol.117, issue.1, pp.211-232, 1989.
DOI : 10.1016/0002-8703(89)90685-6

6. Merlet, P. , N. Guyen, and C. , Tomographie par émission de positons en cardiologie, pp.541-56, 2002.

E. Braullwaid and J. Rutherford, Reversible ischemic 1eft ventricular dysfunction: evidence for the "hibernating myocardium" (Editorial), J Am Coll, vol.8, pp.1467-70, 1986.

C. Murry, R. Jenllillgs, and K. Reimer, Precandiliollillg with ischemia: a de1ay of lethal cell injury in ischemic myocardium, Circulation, vol.5, pp.1124-1160, 1986.

M. Ovize, Le pr??conditionnement : adaptation du cardiomyocyte ?? l'isch??mie, m??decine/sciences, vol.15, issue.3, pp.352-360, 1999.
DOI : 10.4267/10608/1345

Z. Zhao, J. Corvera, and M. Halkos, Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning, American Journal of Physiology-Heart and Circulatory Physiology, vol.285, issue.2, pp.579-88, 2003.
DOI : 10.1152/ajpheart.01064.2002

P. Staat, G. Rioufol, and C. Piot, Postconditioning the Human Heart, Circulation, vol.112, issue.14, pp.2143-2151, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.558122

L. Argaud and . Gateau-, Roesch 0, Raisky 0 ct al. Postconditioning inhibits mitochondrial permeability transition, Circulation, vol.III, pp.194-201, 2005.

R. Van-domburg, V. Miltenburg-van-zijl, A. Veerhoek, and R. , Unstable Angina: Good Long-Term Outcome After a Complicated Early Course, Journal of the American College of Cardiology, vol.31, issue.7, pp.1534-1543, 1998.
DOI : 10.1016/S0735-1097(98)00140-5

J. Canto, C. Fincher, and C. Kiefe, Atypical presentations among medicare beneficiaries with unstable angina pectoris**This material was prepared by the Alabama Quality Assurance Foundation under a contract with the Centers for Medicare and Medicaid Services (CMS). Contents do not necessarily represent CMS policy., The American Journal of Cardiology, vol.90, issue.3, pp.248-53, 2002.
DOI : 10.1016/S0002-9149(02)02463-3

D. Diercks, W. Peacock, and B. Hiestand, Frequency and consequences of recording an electrocardiogram > 10 min after arrivai in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUS ADE Initiative), Am J Cm, vol.97, pp.437-479, 12006.

F. Van-de-werf, D. Ardissino, and A. Betriu, Management of acute myocardial infarction in patients presenting with ST-segment elevation, European Heart Journal, vol.24, issue.1, pp.28-66, 2003.
DOI : 10.1016/S0195-668X(02)00618-8

L. Holmvang, P. Clemmensen, and B. Lindahl, Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment, Journal of the American College of Cardiology, vol.41, issue.6, pp.905-920, 2003.
DOI : 10.1016/S0735-1097(02)02970-4

T. Hyde, J. French, and C. Wong, Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression, The American Journal of Cardiology, vol.84, issue.4, pp.379-85, 1999.
DOI : 10.1016/S0002-9149(99)00319-7

K. Akkerhuis, P. Klootwijk, and W. Lindeboom, Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients, European Heart Journal, vol.22, issue.21, pp.1997-2006, 2001.
DOI : 10.1053/euhj.2001.2750

K. Eggers, J. Oldgren, and A. Nordenskjold, Diagnostic value of seriaI measurement of cardiac markers in patients with ehest pain: Iimited value of adding myoglobin to troponin 1 for exclusion of myocardial infarction

T. Keller, T. Zeller, and D. Peetz, Sensitive Troponin 1 Assay in Early Diagnosis of Aeute Myocardial Infarction

C. Hamm, B. Goldmann, and C. Heeschen, Emergency room triage of patients wilh acute ellest pain by means of rapid testing for cardiac troponin T or troponin I, N ElIgl J Iv, vol.337, pp.1648-53, 1997.

E. Antman, T. Ml, and B. Thompson, Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.335, issue.18, pp.1342-1351, 1996.
DOI : 10.1056/NEJM199610313351802

B. Lindahl, H. Toss, and A. Siegbahn, Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease, N ElIgJ Iv, vol.343, pp.1139-1186, 2000.

D. Morrow, N. Rifai, and E. Antman, C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy, Journal of the American College of Cardiology, vol.31, issue.7, pp.1460-1465, 1998.
DOI : 10.1016/S0735-1097(98)00136-3

T. Jernberg, M. Stridsberg, and P. Venge, N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation, Journal of the American College of Cardiology, vol.40, issue.3, pp.437-482, 2002.
DOI : 10.1016/S0735-1097(02)01986-1

A. Suwaidi-1, D. Reddan, and K. Williams, Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes, Circulation, vol.106, issue.8, pp.974-80, 2002.
DOI : 10.1161/01.CIR.0000027560.41358.B3

F. Masoudi, M. Plolllondoll, and M. Dl, Renal insufficiency and mortality from acute coronary syndromes, American Heart Journal, vol.147, issue.4, pp.623-632, 2004.
DOI : 10.1016/j.ahj.2003.12.010

V. Dharnidharka, C. Kwon, and G. Stevens, Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis, American Journal of Kidney Diseases, vol.40, issue.2, pp.221-227, 2002.
DOI : 10.1053/ajkd.2002.34487

T. Jernbcrg and B. Lindahl, Cystatin C: a novel predictor of outcome in suspeeted or eonfirmed non- ST-elevation aeute coronary syndrome, pp.2342-2350, 12004.

S. Baldus, C. Heeschen, and T. Meinertz, Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes, Circulation, vol.108, issue.12, pp.1440-1445, 2003.
DOI : 10.1161/01.CIR.0000090690.67322.51

N. Vara, D. Lemos-la, and P. Libby, Soluble CD40L: Risk Prediction After Acute Coronary Syndromes, Circulation, vol.108, issue.9, pp.1049-52, 2003.
DOI : 10.1161/01.CIR.0000088521.04017.13

T. Reichlin, Incrementai value of copeptine for rapid rule out of aeute myocardial infarclion. Late-breaking clinical trials. College of Cardiology scientifie sessions, 2009.

!. Cheit, M. Armstrong, W. Aurigemma, and G. , ACC/AHNASE 2003 guide!ine update for the cliniea! application of echocardiography: summary article: a report of the American Collegc of Cardiology, American Heart Association Task Force on Practicc Guidelines (ACC/AHA/ASE Committee to Updatc the !997 Guide!ines for the Clinica! Application of Echocardiography, pp.146-62, 2003.

A. Agatston, W. Janowitz, and F. Hildner, Quantification of coronary artery calcium using ultrafast computed tomography, Journal of the American College of Cardiology, vol.15, issue.4, pp.827-859, 1990.
DOI : 10.1016/0735-1097(90)90282-T

S. 94-plcin, J. Goeenwood, and J. Ridgway, Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonancc imaging, J Alli Coll Cm'diol, vol.44, pp.2173-81, 2004.

9. Garot-l and A. Furber, IRM cardiaque chez le coronarien. Société Française de Cardiologie. Cardiologie et maladies vasculaires, pp.500-507, 2007.

G. Rosey and L. L. Ivus, Société Française de Cardiologie. Cardiologie et maladies vasculaires, pp.512-520, 2007.

. Bassand-lp, Syndromes coronariens aigus sans surélévation du segment ST

E. Braunwald, Unstable angina. A classification, Circulation, vol.80, issue.2, pp.410-414, 1989.
DOI : 10.1161/01.CIR.80.2.410

C. Hamm and E. Braunwald, A Classification of Unstable Angina Revisited, Circulation, vol.102, issue.1, pp.118-140, 2000.
DOI : 10.1161/01.CIR.102.1.118

C. Bcnsouda and N. Oanchin, Aspects cliniques des syndromes coronariens aigus, m??decine/sciences, vol.20, issue.4, pp.402-409, 2004.
DOI : 10.1051/medsci/2004204402

E. Loi-antman, M. Cohen, and B. Pl, The TIMI Risk Score for Unstable Angina/Non???ST Elevation MI, JAMA, vol.284, issue.7, pp.835-877, 2000.
DOI : 10.1001/jama.284.7.835

F. Lapostolle, C. Lapandry, and F. Adnet, Stratégie de prise en charge des syndromes coronaires aigus sans susdécalage du segment ST, Urgences, vol.2, pp.35-46, 2004.

H. Robinson, Mechanism of action ofbeta-blocking drugs in angina pectoris: a review, Postgrad Med J, vol.52, pp.43-48, 1976.

S. Yusuf, W. 1. Friedman, and L. , Overview of resu1ts of randornized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification 10; COMMIT (Clopidogrel and metoprolol in myocardial infarction trial) collaborative group. Addition to clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial, lAMA, vol.260, issue.366, pp.2259-63, 1988.

T. Munzel, A. Daiber, and A. Mulseh, Explaining the Phenomenon of Nitrate Tolerance, Circulation Research, vol.97, issue.7, pp.618-646, 2005.
DOI : 10.1161/01.RES.0000184694.03262.6d

J. Lubsen and J. Tijsscn, Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: Findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT), The American Journal of Cardiology, vol.60, issue.2, pp.18-25, 1987.
DOI : 10.1016/0002-9149(87)90494-2

M. Baruscotti, A. Bucchi, and D. Difrancesco, Physiology and pharmacology of the cardiac pacemaker Cfunny

J. Tardif, F. 1. Tendenl, and M. , Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina, European Heart Journal, vol.26, issue.23, pp.2529-2565, 2005.
DOI : 10.1016/0014-2999(90)90011-T

A. Grynberg, Effeetors of fatty acid axidation reduetian: promising new anti-isehaemie agents, ClflT Pharm Des, vol.II, issue.4, pp.489-509, 2005.

J. Anderson, J. Nawarskas, and . Ranolazine, Ranolazine*, Cardiology in Review, vol.13, issue.4, pp.202-212, 2005.
DOI : 10.1097/01.crd.0000161979.62749.e7

J. Lu-eikelbaom, S. Anand, and K. Malmberg, Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis, The Lancet, vol.355, issue.9219, pp.1936-1978, 2000.
DOI : 10.1016/S0140-6736(00)02324-2

A. Il-''oler, M. Whoaley, and J. Oler, Aclding hepat-in ta aspirin recluccs the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis, 115 Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, pp.811-816, 1996.

J. Petersen, K. Mahaffey, and V. Hasselblad, Efficacy and bleeding complications among patients randomized ta enaxaparin or unfraetionated heparin for antilhrombin therapy in non-ST-Segment elevatioll aeute coronary syndromes: a systematic overview, pp.89-96, 2004.

S. Synthejabo and . Arixtra, Sl/l/Imary of Proc, 2002.

A. Turpie, A. Gallus, and H. La, A synthetie pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement, N ElIgI], vol.344, pp.619-644, 2001.

G. Stone, B. Melaurin, and D. Cax, Bivalirudin for Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.355, issue.21, pp.2203-2219, 2006.
DOI : 10.1056/NEJMoa062437

J. Conard, Agents antiplaquettaires. Société Française de Cardiologie. Cardiologie et maladies vasculaires, pp.1448-56, 2007.

E. Eisenstein, K. Anslrom, and D. Kong, Clopidogrel use and long-term clinical outcomes after drug-eluting stcnt implantation, pp.159-68, 2007.

A. Farb and A. Boam, Stent Thrombosis Redux ??? The FDA Perspective, New England Journal of Medicine, vol.356, issue.10, pp.984-991, 2007.
DOI : 10.1056/NEJMp068304

F. Ii, Invasive compared with non-invasive trcatment in uns table coronary-artery disease: FRISC II prospective randomised mullicentre study. Fragmin and fasl Revascularisation during InStability in Coronary artery disease Investigators, Lallcet, vol.354, pp.708-723, 1999.

S. Rao, J. Eikelboom, and C. Granger, Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes, European Heart Journal, vol.28, issue.10, pp.1193-204, 2007.
DOI : 10.1093/eurheartj/ehm019

M. Us-moscucci, K. Fox, and C. Cannon, Prcdictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE), Ellr Heart, vol.1, issue.24, pp.1815-1838, 2003.

M. Sabatine, D. Morrow, and R. Giugliano, Association of haemoglobin lcvcls with clinical outcomes in acute coronary syndromes, Circulation, vol.III, pp.2042-2051, 2005.

S. Rao, J. Jouis, and R. Harrington, Relationship of blood transfusion and clinÎCal outcomes in patients with acute coronary syndromes, lAMA, vol.292, issue.13, pp.1555-62, 2004.

T. Warkentin and K. Lg, Temporal Aspects of Heparin-Induced Thrombocytopenia, New England Journal of Medicine, vol.344, issue.17, pp.1286-92, 2001.
DOI : 10.1056/NEJM200104263441704

Y. Li, F. Spencer, and R. Becker, Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition, American Heart Journal, vol.143, issue.4, pp.725-757, 2002.
DOI : 10.1067/mhj.2002.120299

K. Fox, P. Poole-wilson, and T. Clayton, 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial, The Lancet, vol.366, issue.9489, pp.914-934, 2005.
DOI : 10.1016/S0140-6736(05)67222-4

S. Mehta, C. Granger, and W. Baden, Early versus Delayed Invasive Intervention in Acute Coronary Syndromes, New England Journal of Medicine, vol.360, issue.21, pp.2165-75, 2009.
DOI : 10.1056/NEJMoa0807986

S. Yusuf, S. Mehta, and S. Chrolavicius, Efficacy and safety of fondaparinux compared to enoxaparin in 20,078 patients with acute coronary syndromes without ST segment elevation. The OASIS (Organization to Assess Strategies in Aeute Ischemie Syndromes)-5 Investigators, Med, vol.354, issue.1, pp.1464-76, 2006.

. De-stampfcr-ml, G. Colditz, and W. Willet, Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study, Med, vol.325, pp.756-62, 1991.

P. Steg and J. Puel, FACT: registre national français des syndromes coronaires aigus: Étude particulière des centres hospitaliers généraux français, Anll Cardiol, vol.52, pp.337-380, 2003.

W. Shell, M. Dewood, and T. Peter, Comparison of clinical signs and hemodynamic state in the early hours of transmural myocardial infarction, American Heart Journal, vol.104, issue.3, pp.521-529, 1982.
DOI : 10.1016/0002-8703(82)90222-8

E. Bonnefoy, F. Lapostolle, and A. Leizorovicz, Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study, The Lancet, vol.360, issue.9336, pp.825-834, 2002.
DOI : 10.1016/S0140-6736(02)09963-4

L. Svensson, C. Axelsson, and R. Nordlander, Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due la a suspected acute coronary syndrome, J /Iltem, vol.255, issue.4, pp.469-77, 2004.

P. Sauvai and A. Greffet, Prise en charge préhospitalière des syndromes coronaires. Société Française de Cardiologie. Cardiologie et maladies vasclllaires, pp.118-142, 2007.

M. Makijarvi and T. Silfvast, Prehospîtal ECG transmission: comparison of advanced mobile phone and facsimilc devices in an urban Emergency Medical Service System, ReSllscitatioll, vol.57, issue.2, pp.179-85, 2003.

C. Lapandry, T. Laperche, and Y. Lambert, Prise en charge préhospitalière des syndromes coronaires aigus ST+ en Ile-de-France. Le registre E-MUST, Arch Mal Coellr, vol.98, pp.1137-1179, 2005.

P. Carli, G. Hanania, and P. Sauvai, Pour le groupe de travail Stim-Samu. Résultats de l'étude Stim-Samu, La Revue des Sallill, pp.191-196, 2001.

S. Ellis, P. Armstrong, and A. Betriu, Facilitated percutaneous coronary intervention vs primary percutaneous coronary intervention: design and rationale of the facilitated intervention with enhanced reperfusion speed 10 stop events (FINESSE) trial. Alli, Henrt J, vol.147, p.16, 2004.

M. Gevrey and . Timacs, on peut temporiser pour les SCA ST-à bas risque. thehenrt.org, International Editions> Édition française> Sections> Actualités, 2007.

J. Bonnet, Unité dédiée à la prise en charge des douleurs thoraciques aiguës ou «Chest Pain Unit ». Société Française de Cardiologie. Cardiologie et maladies vasclllaires, pp.550-552, 2007.

J. Machecourt, Place de l'angioplastie dans la prise en charge du coronarien

G. The and . Investigators, An international randomized trial comparing four thrombolytic strategies for acute myocardial infarctioll, N ElIgl J Med, vol.329, pp.673-82, 1993.

E. Pendant and L. Transfert, Signes périphériques de choc OUI 0 NON 0 l)ersistancc douleur OUI 0